• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

Epidemiology: The global burden of reduced GFR: ESRD, CVD and mortality.

作者信息

Sharma Shilpa, Sarnak Mark J

机构信息

Renal Division, Department of Medicine, Brigham and Women's Hospital, 75 Francis Street, Boston, Massachusetts 02115, USA.

Division of Nephrology, Department of Medicine, Tufts University School of Medicine, Box 391, 800 Washington Street, Boston, Massachusetts 02111, USA.

出版信息

Nat Rev Nephrol. 2017 Aug;13(8):447-448. doi: 10.1038/nrneph.2017.84. Epub 2017 Jun 19.

DOI:10.1038/nrneph.2017.84
PMID:28626221
Abstract
摘要

相似文献

1
Epidemiology: The global burden of reduced GFR: ESRD, CVD and mortality.流行病学：肾小球滤过率降低的全球负担：终末期肾病、心血管疾病和死亡率。
Nat Rev Nephrol. 2017 Aug;13(8):447-448. doi: 10.1038/nrneph.2017.84. Epub 2017 Jun 19.
2
Cardiovascular mortality in end-stage renal disease.终末期肾病中的心血管死亡率。
Am J Med Sci. 2003 Apr;325(4):163-7. doi: 10.1097/00000441-200304000-00002.
3
Cardiovascular outcomes in high-risk hypertensive patients stratified by baseline glomerular filtration rate.根据基线肾小球滤过率分层的高危高血压患者的心血管结局
Ann Intern Med. 2006 Feb 7;144(3):172-80. doi: 10.7326/0003-4819-144-3-200602070-00005.
4
Cystatin C identifies cardiovascular risk better than creatinine-based estimates of glomerular filtration in middle-aged individuals without a history of cardiovascular disease.胱抑素 C 比基于肌酐的肾小球滤过率估计在中年人群中更好地识别心血管风险，这些人群没有心血管疾病史。
J Intern Med. 2014 May;275(5):506-21. doi: 10.1111/joim.12169. Epub 2013 Dec 20.
5
Improved survival and renal prognosis of patients with type 2 diabetes and nephropathy with improved control of risk factors.改善危险因素控制可提高 2 型糖尿病肾病患者的生存率和肾脏预后。
Diabetes Care. 2014 Jun;37(6):1660-7. doi: 10.2337/dc13-2036. Epub 2014 Mar 12.
6
Automatic reporting of the estimated glomerular filtration rate (eGFR).估算肾小球滤过率（eGFR）的自动报告。
N C Med J. 2008 May-Jun;69(3):215-8.
7
Antioxidants for chronic kidney disease.用于慢性肾病的抗氧化剂。
Nephrology (Carlton). 2013 Aug;18(8):576-8. doi: 10.1111/nep.12103.
8
Renal function and serum albumin at the start of dialysis in 514 Chinese ESRD in-patients.514例中国终末期肾病住院患者透析开始时的肾功能和血清白蛋白水平
Ren Fail. 2008;30(7):685-90. doi: 10.1080/08860220802212619.
9
Morbidity, mortality and economic burden of renal impairment in cardiac intensive care.心脏重症监护中肾功能损害的发病率、死亡率及经济负担
Intern Med J. 2006 Mar;36(3):185-92. doi: 10.1111/j.1445-5994.2006.01012.x.
10
Cardiorenal risk factors.心肾危险因素。
Am J Med Sci. 2010 Jul;340(1):25-9. doi: 10.1097/MAJ.0b013e3181e59078.

引用本文的文献

1
Mechanisms of exercise in preventing cardiovascular diseases: Insights from gut microbiota characteristics in pathological states of cardiovascular diseases.运动预防心血管疾病的机制：从心血管疾病病理状态下的肠道微生物群特征中获得的见解
Rev Endocr Metab Disord. 2025 Jun 9. doi: 10.1007/s11154-025-09971-8.
2
Association of dietary index of gut microbiota with cardiovascular disease risk: new evidence from NHANES 2007-2018.肠道微生物群饮食指数与心血管疾病风险的关联：来自2007 - 2018年美国国家健康与营养检查调查（NHANES）的新证据
BMC Cardiovasc Disord. 2025 Apr 28;25(1):332. doi: 10.1186/s12872-025-04776-8.
3
Association of the remnant cholesterol to high-density lipoprotein cholesterol ratio with mortality in peritoneal dialysis patients.

本文引用的文献

1
Global Cardiovascular and Renal Outcomes of Reduced GFR.肾小球滤过率降低的全球心血管和肾脏结局
J Am Soc Nephrol. 2017 Jul;28(7):2167-2179. doi: 10.1681/ASN.2016050562. Epub 2017 Apr 13.
2
Global, regional, and national disability-adjusted life-years (DALYs) for 315 diseases and injuries and healthy life expectancy (HALE), 1990-2015: a systematic analysis for the Global Burden of Disease Study 2015.1990 - 2015年全球、区域和国家315种疾病和损伤的伤残调整生命年（DALYs）及健康预期寿命（HALE）：全球疾病负担研究2015的系统分析
Lancet. 2016 Oct 8;388(10053):1603-1658. doi: 10.1016/S0140-6736(16)31460-X.
3
Chronic kidney disease and cardiovascular risk in six regions of the world (ISN-KDDC): a cross-sectional study.
腹膜透析患者中残余胆固醇与高密度脂蛋白胆固醇比值与死亡率的关联。
Lipids Health Dis. 2025 Mar 21;24(1):107. doi: 10.1186/s12944-025-02522-9.
4
The association between the atherogenic index of plasma and all-cause mortality in patients undergoing peritoneal dialysis: a multicenter cohort study.血浆致动脉粥样硬化指数与腹膜透析患者全因死亡率之间的关联：一项多中心队列研究。
Lipids Health Dis. 2025 Mar 13;24(1):91. doi: 10.1186/s12944-025-02510-z.
5
Defining the predictors for post renal transplant left ventricular dysfunction in end-stage renal disease patients.确定终末期肾病患者肾移植后左心室功能障碍的预测因素。
Physiol Rep. 2025 Feb;13(3):e70198. doi: 10.14814/phy2.70198.
6
Metformin for preventing the progression of chronic kidney disease.二甲双胍预防慢性肾脏病进展。
Cochrane Database Syst Rev. 2024 Jun 4;6(6):CD013414. doi: 10.1002/14651858.CD013414.pub2.
7
Comparison of METS-IR and HOMA-IR for predicting new-onset CKD in middle-aged and older adults.METS-IR与HOMA-IR在预测中老年人群新发慢性肾脏病方面的比较。
Diabetol Metab Syndr. 2023 Nov 14;15(1):230. doi: 10.1186/s13098-023-01214-7.
8
Elevated triglyceride-glucose index predisposes to the initial episode of peritonitis in chronic peritoneal dialysis patients.甘油三酯-葡萄糖指数升高与慢性腹膜透析患者腹膜炎首发相关。
Ren Fail. 2023;45(2):2267127. doi: 10.1080/0886022X.2023.2267127. Epub 2023 Oct 9.
9
Analysis of the potential biological mechanisms of diosmin against renal fibrosis based on network pharmacology and molecular docking approach.基于网络药理学和分子对接方法分析橙皮苷防治肾纤维化的潜在生物学机制。
BMC Complement Med Ther. 2023 May 13;23(1):157. doi: 10.1186/s12906-023-03976-z.
10
Kidney transplantation: a possible solution to obstructive sleep apnea in patients with end-stage kidney disease.肾移植：终末期肾病患者阻塞性睡眠呼吸暂停的一种可能解决方案。
Sleep Breath. 2023 Oct;27(5):1667-1675. doi: 10.1007/s11325-023-02803-6. Epub 2023 Mar 16.
世界六个地区的慢性肾脏病和心血管风险（ISN-KDDC）：一项横断面研究。
Lancet Glob Health. 2016 May;4(5):e307-19. doi: 10.1016/S2214-109X(16)00071-1.
4
Global, regional, and national comparative risk assessment of 79 behavioural, environmental and occupational, and metabolic risks or clusters of risks in 188 countries, 1990-2013: a systematic analysis for the Global Burden of Disease Study 2013.1990年至2013年188个国家79种行为、环境与职业以及代谢风险或风险群组的全球、区域和国家比较风险评估：全球疾病负担研究2013的系统分析
Lancet. 2015 Dec 5;386(10010):2287-323. doi: 10.1016/S0140-6736(15)00128-2. Epub 2015 Sep 11.
5
A systematic analysis of worldwide population-based data on the global burden of chronic kidney disease in 2010.2010年全球慢性肾脏病负担的全球人群数据的系统分析。
Kidney Int. 2015 Nov;88(5):950-7. doi: 10.1038/ki.2015.230. Epub 2015 Jul 29.
6
Changes in albuminuria predict mortality and morbidity in patients with vascular disease.尿白蛋白变化可预测血管疾病患者的死亡率和发病率。
J Am Soc Nephrol. 2011 Jul;22(7):1353-64. doi: 10.1681/ASN.2010091001. Epub 2011 Jun 30.
7
Age affects outcomes in chronic kidney disease.年龄影响慢性肾脏病的预后。
J Am Soc Nephrol. 2007 Oct;18(10):2758-65. doi: 10.1681/ASN.2007040422. Epub 2007 Sep 12.